Residual Sleep-Related Respiratory Events During Early Versus Long-Term NIV Follow-Up: Burden and Relationship with Gas Exchange
8 affiliations
- 1Department of Pulmonology, Croix-Rousse Hospital, Hospices Civils de Lyon, 69004 Lyon, France
- 2Research on Healthcare Performance (RESHAPE), INSERM U1290, University Claude Bernard Lyon 1, 69373 Lyon, France
- 3Hypoxie Physiopathologie (HP2), INSERM U1300, University Grenoble Alpes, 38058 Grenoble, France
- 4Institut Universitaire du Poumon, Centre de Référence Constitutif des Maladies Pulmonaires Rares de l’Adulte, Centre Hospitalo-Universitaire Dijon-Bourgogne, 21000 Dijon, France
- 5Faculty of Medicine and Pharmacy, University Bourgogne Europe, 21000 Dijon, France
- 6Centre des Sciences du Goût et de l’Alimentation, INRAE, UMR 6265 CNRS 1234, University Bourgogne Europe, 21000 Dijon, France
- 7Division of Pulmonary Medicine, Lausanne University Hospital (CHUV), University of Lausanne, CH-1011 Lausanne, Switzerland
- 8Center for Translational and Molecular Medicine (CTM), INSERM U1231, University Bourgogne Europe, 21000 Dijon, France
Abstract
Background: A recent study published by our group demonstrated that patient–ventilator asynchrony (PVA) is independently associated with impaired gas exchange during long-term non-invasive ventilation (NIV). We aimed to determine whether the burden and phenotype of residual PVA vary according to disease category, NIV initiation context and follow-up timing, and whether the relationship between PVA and gas exchange differs according to follow-up timing. Methods: We performed a secondary analysis of 123 NIV-treated patients included in the primary study. PVA burden, upper-airway obstructive events and leaks were compared across disease categories and follow-up settings. Multivariable models for gas exchange outcomes were extended by introducing interaction terms between PVA burden and follow-up category. Patients underwent either long-term follow-up performed >3 months after NIV initiation (n = 74), early acute follow-up, i.e., after stabilization following NIV initiation in acute respiratory failure (n = 30), or early planned follow-up, i.e., within 3 months after NIV initiation in stable chronic respiratory failure (CRF) (n = 19). Results: Overall, leaks, upper airway obstructions (UAOs) and PVA burden did not significantly differ across disease categories, and neither leaks nor UAO differed across follow-up categories. In contrast, patients undergoing early follow-up after acute NIV initiation exhibited a significantly greater burden of residual PVA than those initiated in stable CRF, predominantly because of ineffective efforts. Within the subgroup of patients undergoing early follow-up, total PVA burden was more than doubled after acute NIV initiation (4.5% versus 1.5% of recording time; 6.2 versus 2.5 events·h−1). The association between PVA burden and post-NIV PaCO2 did not differ according to follow-up timing. Conversely, in an exploratory analysis limited to 40 patients, the relationship between PVA burden and nocturnal TcPCO2 was significantly attenuated during early compared with long-term follow-up (interaction β = −1.04, 95% CI −1.68 to −0.40; p = 0.003). However, this interaction was attenuated after adjustment for daytime PaCO2 (β = −0.55, 95% CI −1.12 to 0.03; p = 0.076). Stratified analyses demonstrated significant associations between PVA burden and both post-NIV PaCO2 (β = 0.38, p = 0.034) and nocturnal TcPCO2 (β = 0.80, p < 0.001) during routine long-term follow-up. Conclusions: Patients evaluated after acute NIV initiation exhibited the highest burden of residual PVA, predominantly ineffective efforts. However, PVA was independently associated with nocturnal hypercapnia primarily during established long-term NIV. These findings should be considered hypothesis-generating and require confirmation in larger prospectively monitored cohorts.
Related
- Relationship between autistic traits, emotional symptoms and adverse life events in Chinese adolescents: mediating effects of resilience
- Presence of Dolosigranulum pigrum in the nasopharynx and its relationship with respiratory health status in paediatric population
- Immune checkpoint inhibitors and the inflammatory dysregulation: decoding cutaneous and gastrointestinal immune-related adverse events for the allergist and immunologist
- 1085 Educational intervention to increase utilization of ICD-10 codes for immune-related adverse events: a quality improvement initiative
- Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach
BibTeX
@article{tankere2026residual,
title = {{Residual Sleep-Related Respiratory Events During Early Versus Long-Term NIV Follow-Up: Burden and Relationship with Gas Exchange}},
author = {Pierre Tankéré and Marjolaine Georges and Ameline Vagner and Jade Chorvoz and Geoffroy Mery and Cedric Bongard and Philippe Bonniaud and Claudio Rabec},
journal = {Journal of clinical medicine},
year = {2026},
month = oct,
doi = {10.3390/jcm15197695},
url = {https://europepmc.org/article/PMC/PMC13665768},
note = {CC BY},
}
RIS
TY - JOUR
TI - Residual Sleep-Related Respiratory Events During Early Versus Long-Term NIV Follow-Up: Burden and Relationship with Gas Exchange
AU - Pierre Tankéré
AU - Marjolaine Georges
AU - Ameline Vagner
AU - Jade Chorvoz
AU - Geoffroy Mery
AU - Cedric Bongard
AU - Philippe Bonniaud
AU - Claudio Rabec
PY - 2026
DA - 2026/10/01
JO - Journal of clinical medicine
DO - 10.3390/jcm15197695
UR - https://europepmc.org/article/PMC/PMC13665768
AB - Background: A recent study published by our group demonstrated that patient–ventilator asynchrony (PVA) is independently associated with impaired gas exchange during long-term non-invasive ventilation (NIV). We aimed to determine whether the burden and phenotype of residual PVA vary according to disease category, NIV initiation context and follow-up timing, and whether the relationship between PVA and gas exchange differs according to follow-up timing. Methods: We performed a secondary analysis of 123 NIV-treated patients included in the primary study. PVA burden, upper-airway obstructive events and leaks were compared across disease categories and follow-up settings. Multivariable models for gas exchange outcomes were extended by introducing interaction terms between PVA burden and follow-up category. Patients underwent either long-term follow-up performed >3 months after NIV initiation (n = 74), early acute follow-up, i.e., after stabilization following NIV initiation in acute respiratory failure (n = 30), or early planned follow-up, i.e., within 3 months after NIV initiation in stable chronic respiratory failure (CRF) (n = 19). Results: Overall, leaks, upper airway obstructions (UAOs) and PVA burden did not significantly differ across disease categories, and neither leaks nor UAO differed across follow-up categories. In contrast, patients undergoing early follow-up after acute NIV initiation exhibited a significantly greater burden of residual PVA than those initiated in stable CRF, predominantly because of ineffective efforts. Within the subgroup of patients undergoing early follow-up, total PVA burden was more than doubled after acute NIV initiation (4.5% versus 1.5% of recording time; 6.2 versus 2.5 events·h−1). The association between PVA burden and post-NIV PaCO2 did not differ according to follow-up timing. Conversely, in an exploratory analysis limited to 40 patients, the relationship between PVA burden and nocturnal TcPCO2 was significantly attenuated during early compared with long-term follow-up (interaction β = −1.04, 95% CI −1.68 to −0.40; p = 0.003). However, this interaction was attenuated after adjustment for daytime PaCO2 (β = −0.55, 95% CI −1.12 to 0.03; p = 0.076). Stratified analyses demonstrated significant associations between PVA burden and both post-NIV PaCO2 (β = 0.38, p = 0.034) and nocturnal TcPCO2 (β = 0.80, p < 0.001) during routine long-term follow-up. Conclusions: Patients evaluated after acute NIV initiation exhibited the highest burden of residual PVA, predominantly ineffective efforts. However, PVA was independently associated with nocturnal hypercapnia primarily during established long-term NIV. These findings should be considered hypothesis-generating and require confirmation in larger prospectively monitored cohorts.
SN - 2077-0383
ER -